[ Price : $8.95]
A just-post FDA untitled letter cites Daiichi Sankyo for making misleading claims in a mailer to health professionals for hyperten...[ Price : $8.95]
FDA objects to statements made by Aegerion Pharmaceuticals CEO Marc Beer on CNBCs Fast Money program that it says broadened the in...[ Price : $8.95]
Federal Register Notice: FDA determines that several drug products were not withdrawn from sale for reasons of safety or effective...[ Price : $8.95]
Erytech Pharma says an independent Data and Safety Monitoring Board completed its first assessment of a Phase 2b study evaluating ...[ Price : $8.95]
A Centers for Disease Control and Prevention study says emergency department visits associated with OTC pediatric cough cold medic...[ Price : $8.95]
Federal Register Notice: FDAs Endocrinologic and Metabolic Drugs Advisory Committee will meet 12/12 to discuss a Bristol-Myers Squ...[ Price : $8.95]
Federal Register Notice: FDAs Circulatory System Devices Panel will meet 12/11 to vote on a Boston Scientific PMA for the WATCHMAN...[ Price : $8.95]
A Phase 3B/4 study involving Pfizers Rapamune in kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) t...